Overview of AOD-9604 as a Research Peptide
AOD-9604 is a synthetic peptide fragment that has attracted significant interest within the scientific community for its role in laboratory investigations. Derived from the C‑terminal region of human growth hormone (hGH), specifically amino acids 177–191, this 16‑mer peptide is chemically defined and produced under controlled conditions. Researchers study AOD-9604 primarily to understand lipid metabolism, cellular signaling pathways, and related metabolic processes. As a non‑clinical research tool, it is used solely in in vitro models and in authorized animal studies to explore biochemical mechanisms. No therapeutic or diagnostic properties are implied, and all applications remain within the scope of fundamental research.
The growing demand for AOD-9604 has led to a diverse supply base, with China emerging as a key location for peptide synthesis and export. When sourcing from an AOD-9604 manufacturer in China, institutions and distributors seek suppliers that adhere to rigorous quality benchmarks and provide transparent documentation. This article outlines the critical scientific, manufacturing, and regulatory aspects that inform the selection of a reliable research peptide supplier.
Chemical Structure and Properties
The molecular structure of AOD-9604 is well‑characterized. The peptide comprises 16 amino acids with the sequence Tyr‑Leu‑Arg‑Ile‑Val‑Gln‑Cys‑Arg‑Ser‑Val‑Glu‑Gly‑Ser‑Cys‑Gly‑Phe, containing an intramolecular disulfide bridge between the two cysteine residues. Its molecular formula is C78H123N21O23S2, corresponding to a molecular weight of approximately 1811.0 g/mol. Manufacturers routinely confirm these parameters through advanced analytical techniques.
For research applications, purity levels typically exceed 98%, as verified by high‑performance liquid chromatography (HPLC). Residual impurities, including trifluoroacetic acid (TFA) counter‑ions, are minimized during the purification process. The lyophilized powder is hygroscopic and must be stored at –20 °C in a desiccated environment to preserve stability over extended periods. Short‑term handling at 2–8 °C is acceptable, but repeated freeze‑thaw cycles should be avoided to prevent aggregation. These storage and handling requirements are documented in peer‑reviewed literature and are standard for synthetic peptides of this class.
Mechanism of Interest in Laboratory Studies
In vitro assays have demonstrated that AOD-9604 can interact with receptors on differentiated adipocytes, modulating lipolytic activity and inhibiting the differentiation of pre‑adipocytes into mature fat cells. Studies using 3T3‑L1 murine cell lines show that the peptide influences the expression of genes involved in lipid storage and energy expenditure, although the exact binding partners remain under investigation.
In vivo research employs rodent models of diet‑induced obesity to examine metabolic regulation. Published data indicate that chronic administration of AOD-9604 in these models leads to reduced body weight gain and improved insulin sensitivity, without the broad anabolic effects associated with full‑length growth hormone. Mechanistic pathways under exploration include the activation of hormone‑sensitive lipase, modulation of AMP‑activated protein kinase (AMPK), and crosstalk with peroxisome proliferator‑activated receptors (PPARs). It is important to note that these findings are confined to animal and cellular paradigms and do not extrapolate to human or clinical contexts.
Manufacturing Standards for Research Peptides in China
Chinese manufacturers that supply AOD-9604 to international research markets operate within a framework of quality guidelines that align with global expectations. Reputable producers adopt current Good Manufacturing Practices (cGMP) as the foundation for their operations, ensuring batch‑to‑batch consistency and product integrity. This commitment is evidenced by the traceability maintained from raw material sourcing through final product release, a practice that enables full auditability for procurement teams.
Many facilities are certified to ISO 9001 or hold specific cGMP certifications issued by recognized third‑party bodies. These certifications require periodic renewal and surveillance audits, which verify that manufacturing, testing, and storage processes meet predetermined specifications. For a researcher or distributor evaluating an AOD-9604 manufacturer in China, such credentials provide an initial indicator of operational maturity.
cGMP Compliance and Quality Control
cGMP compliance in peptide manufacturing involves a systematic approach to quality. Regular internal and external audits ensure that production environments maintain appropriate cleanliness, personnel follow validated protocols, and equipment is calibrated. In‑process testing during synthesis monitors coupling efficiency, while intermediate purity checks detect deviations early. The entire process, from solid‑phase assembly to cleavage, purification, and lyophilization, is documented in batch records that are retained for review.
Final product analysis is multi‑faceted. High‑performance liquid chromatography (HPLC) confirms purity and identifies any closely eluting impurities. Mass spectrometry (electrospray ionization, ESI‑MS) verifies molecular weight and sequence integrity. Additional tests may include amino acid analysis, peptide content determination, and pH measurement of reconstituted samples. These controls collectively ensure that the AOD-9604 delivered to research laboratories is fit for its intended experimental purpose.
Purity Analysis and Certification
With every batch of AOD-9604, a Certificate of Analysis (CoA) is issued. This document lists the actual purity value (commonly >98% by HPLC), retention time, mass spectrometry data, and results of tests for residual organic solvents, counter‑ion content, and endotoxin levels. For research applications requiring even greater stringency, purity levels of >99% can be sourced, often using additional polishing steps. The CoA serves as a verifiable statement of quality and is essential for publications that require disclosure of reagent sources.
Endotoxin testing, typically conducted via the Limulus Amebocyte Lysate (LAL) assay, is critical when the peptide will be used in cell culture or animal studies. A common specification is ≤1 EU/mg. Residual solvent levels are measured by gas chromatography and must comply with the limits set by pharmacopoeial guidelines, even though the product is not for clinical or veterinary application.
Selecting a Reliable AOD-9604 Manufacturer in China
Procurement decisions for research peptides involve more than just price comparison. Research institutions and pharmaceutical distributors must perform due diligence to mitigate risks of substandard material, which can compromise experimental data. Key steps include verifying the manufacturer’s credentials, requesting comprehensive documentation, and evaluating the responsiveness of customer support.
A credible AOD-9604 manufacturer in China will openly share information about their synthesis scale, purification capabilities, and quality systems. They should also provide references or examples of successful shipments to peer institutions. Communication before and after an order—regarding technical questions, documentation, or logistics—is a reliable indicator of reliability.
Facility Audits and Documentation
While not all buyers can perform on‑site visits, the best manufacturers are willing to accommodate third‑party audits, whether in person or via virtual inspection. An audit checklist typically covers equipment validation, environmental monitoring, cleaning procedures, and documentation practices. Full documentation packages include signed batch records, raw data from analytical tests, stability study protocols, and reports that detail the shelf‑life of the lyophilized peptide under recommended storage conditions.
Additionally, compliance with international shipping regulations is non‑negotiable. Manufacturers must correctly classify research peptides for export, provide safety data sheets (SDS) that outline handling precautions, and ensure that outer packaging bears clear “For Research Use Only” labeling. Such diligence prevents customs delays and legal complications.
Supply Chain and Logistics Considerations
Peptides are delicate molecules that can degrade if exposed to heat or moisture during transit. Lead times from synthesis to delivery therefore include lyophilization, quality control release, and carefully planned logistics. For bulk orders or sensitive peptides, cold chain packaging using insulated containers and validated temperature loggers may be employed, even though AOD-9604 in its dry powder form is more stable than many other biologics. Buyers should clarify whether the manufacturer uses dessicants and vacuum sealing to maintain dryness.
Customs clearance support is another value‑added service. Reputable suppliers will provide the necessary commercial invoice, airway bill, and pro‑forma documents with accurate harmonized tariff codes. They can also advise on any import permits that the recipient country may require, although the ultimate responsibility for compliance rests with the importing institution.
Regulatory and Legal Framework for Research Peptide Export
Chinese export policies for research peptides are clear: substances that are not intended for human or veterinary use and are labeled accordingly can be shipped as “laboratory reagents” or “research chemicals.” Proper labeling, with statements such as “For research use only. Not for diagnostic or therapeutic purposes,” is mandatory. Furthermore, the Harmonized System (HS) code applicable to peptides—typically 2933.99 or a similar subheading—must be correctly declared to avoid misclassification by customs authorities.
Importing countries may have their own specific requirements. Some jurisdictions classify AOD-9604 as a chemical substance subject to notification under REACH if quantities exceed threshold limits. Buyers should consult their institution’s legal department or a customs broker to pre‑clear any regulatory hurdles. It is the responsibility of the recipient to confirm that the intended use falls strictly within basic research activities.
Import/Export Policies
For small research quantities—ranging from milligrams to a few grams—export permits are not typically required from Chinese authorities, provided the material is not a controlled substance. However, larger commercial quantities, especially when intended for redistribution, may trigger additional export licensing. The Shipper’s Declaration for Dangerous Goods is usually not needed because lyophilized peptides are not considered hazardous under IATA regulations, though the accompanying Safety Data Sheet should be consulted for any specific classification.
Harmonized tariff codes must be applied with precision. Misclassification can lead to fines or seizure of the shipment. Collaborating with a manufacturer experienced in international logistics minimizes these risks. Many suppliers provide a landed‑cost estimate that includes duties and taxes, aiding budget planning for research organizations.
Intellectual Property Considerations
AOD-9604 itself is not subject to active composition‑of‑matter patents that would restrict its research use. The core sequence and some early applications were disclosed in patents that have since expired in most jurisdictions. This allows manufacturers to freely synthesize the peptide for laboratory applications. However, individual producers may have developed proprietary improvements in synthesis, purification, or formulation that afford higher purity or stability. Such process innovations can be protected by trade secrets or utility models.
When entering negotiations for bulk supply, it is common for parties to sign non‑disclosure agreements (NDAs) to protect confidential information shared during technical discussions, such as novel conjugation methods or custom packaging solutions. Buyers should not hesitate to propose an NDA to safeguard their own research interests as well.
Frequently Asked Questions (FAQ)
Below are answers to common inquiries received by AOD-9604 manufacturer in China companies, organized to help researchers and procurement officers make informed decisions. These address purity, synthesis methodology, documentation, and shipping conditions. Importantly, all products discussed are exclusively intended for laboratory research and must never be used in humans or animals outside of approved experimental protocols.
What purity levels are available?
Standard catalog offerings typically present purity levels of >95% and >98% as verified by reverse‑phase HPLC. The >98% grade is preferred for quantitative biological assays and animal studies, where even minor impurities could confound results. Upon request, manufacturers can produce material exceeding >99% purity, often through an additional high‑resolution purification step. Each batch is supplied with a Certificate of Analysis that details the exact purity, mass spectrum, and residual solvent content, allowing researchers to judge suitability for their specific protocol.
How is AOD-9604 synthesized?
The standard production method is solid‑phase peptide synthesis (SPPS), employing Fmoc (9‑fluorenylmethyloxycarbonyl) chemistry. During synthesis, the peptide chain is assembled on a resin support one amino acid at a time, with coupling and deprotection steps optimized to maximize yield and minimize racemization. After chain assembly, the disulfide bridge is formed through oxidative folding in solution, and the crude peptide is cleaved from the resin. Purification is carried out via preparative HPLC, and the product is lyophilized to obtain a stable, dry powder. The final material is aliquoted under controlled humidity and stored according to documented stability protocols.
Research use only note: All information provided in this article pertains solely to the use of AOD-9604 as a laboratory research reagent. No statements should be interpreted as recommending the substance for medical, veterinary, or diagnostic applications. Institutions and researchers are responsible for ensuring that their use complies with all applicable laws, regulations, and institutional ethical guidelines.
For research use only. Not for human or veterinary use.
